T 2161/19 (C1-INH COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF HEREDITARY ANGIOEDEMA (HAE)./ViroPharma Biologics LLC) of 24.03.2022

European Case Law Identifier: ECLI:EP:BA:2022:T216119.20220324
Date of decision: 24 March 2022
Case number: T 2161/19
Petition for review of: -
Application number: 14762343.3
IPC class: A61K 38/16 A61K 38/55 A61K 38/57 A61K 38/00 A61K 38/48 A61P 31/00
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: C1-INH COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF HEREDITARY ANGIOEDEMA (HAE).
Applicant name: ViroPharma Biologics LLC
Opponent name: Octapharma AG
Board: 3.3.07
Headnote: -
Relevant legal provisions: European Patent Convention Art 111 European Patent Convention Art 113(2)
Keywords: Agreement to text of patent withdrawn
Appealed decision becomes final
Appealed decision - patent revoked
Catchword: -
Cited cases: T 0018/92 T 0481/96 T 1226/18
Citing cases: -

Order

For these reasons it is decided that:

The appeal proceedings are terminated. The decision of the opposition division revoking the patent becomes final.